Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Clinical trial NCT02583464 · COMPLETED

Trial details

NCT number: NCT02583464
Sponsor: Laboratorio Elea Phoenix S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome

Start date: 2014-09-01
Primary completion: 2014-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.